{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:53:43Z","timestamp":1775184823254,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.rcsop.2025.100699","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T17:11:00Z","timestamp":1766423460000},"page":"100699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Improved persistence to statin therapy through a patient counseling intervention in community pharmacies \u2013 A nationwide cohort study"],"prefix":"10.1016","volume":"21","author":[{"given":"Karin","family":"Svensberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Wettermark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna Ramsin","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadhossein","family":"Hajiebrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Ekenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albin","family":"Tranberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"K\u00e4lvemark Sporrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2025.100699_bb0005","series-title":"MEDI-VOICE ReportProject ID: 17893","author":"European Commission\/Medi-Voice","year":"2011"},{"key":"10.1016\/j.rcsop.2025.100699_bb0010","series-title":"Adherence to Long-Term Therapies: Evidence for Action","author":"World Health Organization","year":"2003"},{"key":"10.1016\/j.rcsop.2025.100699_bb0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1742-1241.2007.01630.x","article-title":"The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review","volume":"62","author":"Cramer","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.rcsop.2025.100699_bb0020","series-title":"Investing in Medication Adherence Improves Health Outcomes and Health System Efficiency: Adherence to Drugs for Diabetes, Hypertension, and Hyperlipidaemia. OECD Health Working Papers, 105","author":"Khan","year":"2018"},{"key":"10.1016\/j.rcsop.2025.100699_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European atherosclerosis society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rcsop.2025.100699_bb0030","doi-asserted-by":"crossref","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. GBD-NHLBI-JACC global burden of cardiovascular diseases writing group. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 Study. J Am Coll Cardiol 2020;76:2982\u20133021.","DOI":"10.1016\/j.jacc.2020.11.010"},{"issue":"9493","key":"10.1016\/j.rcsop.2025.100699_bb0035","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.rcsop.2025.100699_bb0040","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/14779072.2024.2398444","article-title":"Closing the gap between guidelines and clinical practice for managing dyslipidemia: where are we now?","volume":"22","author":"Sheth","year":"2024","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.rcsop.2025.100699_bb0045","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2025.100699_bb0050","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/03007995.2017.1281109","article-title":"A systematic review to assess adherence and persistence with statins","volume":"33","author":"Deshpande","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rcsop.2025.100699_bb0055","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","article-title":"Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients","volume":"125","author":"Naderi","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.rcsop.2025.100699_bb0060","series-title":"Value of Statins  Patterns of Use and Adherence to Treatment","author":"Anveden Berglind","year":"2013"},{"key":"10.1016\/j.rcsop.2025.100699_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0738-3991(02)00032-0","article-title":"Self-management approaches for people with chronic conditions: a review","volume":"48","author":"Barlow","year":"2002","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.rcsop.2025.100699_bb0070","first-page":"31","article-title":"Delivery of patient adherence support: a systematic review of the role of pharmacists and doctors","volume":"6","author":"Andersson","year":"2014","journal-title":"Patient Intell"},{"key":"10.1016\/j.rcsop.2025.100699_bb0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s40545-023-00626-0","article-title":"Global landscape of community pharmacy services remuneration: a narrative synthesis of the literature","volume":"16","author":"Hussain","year":"2023","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.rcsop.2025.100699_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.sapharm.2019.04.010","article-title":"Community pharmacist led medication reviews in the UK: a scoping review of the medicines use review and the new medicine service literatures","volume":"16","author":"Stewart","year":"2020","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2025.100699_bb0085","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.sapharm.2015.08.002","article-title":"Evaluation of a pharmacy service helping patients to get a good start in taking their new medications for chronic diseases","volume":"2","author":"Kaae","year":"2016","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2025.100699_bb0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/ijpp.12598","article-title":"Effect of a pharmacist-led intervention on adherence among patients with a first-time prescription for a cardiovascular medicine: a randomized controlled trial in Norwegian pharmacies","volume":"28","author":"Hovland","year":"2020","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.rcsop.2025.100699_bb0095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.sapharm.2016.02.001","article-title":"Evaluating the implementation fidelity of new medicines service for asthma patients in community pharmacies in Belgium","volume":"13","author":"Fraeyman","year":"2017","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2025.100699_bb0100","doi-asserted-by":"crossref","unstructured":"Mongaret C, Lepage C, Aubert L, Lestrille A, Slimano F. Quel bilan \u00e0 deux ans de la mise en place de l'accompagnement des patients trait\u00e9s par anti-vitamines K ? Outcomes after a 2-year pharmaceutical care program for patients taking vitamin K antagonist therapy? Community pharmacist's perception. Le point de vue du pharmacien d'officine. Ann Pharm Fr 76 (2).","DOI":"10.1016\/j.pharma.2017.11.004"},{"key":"10.1016\/j.rcsop.2025.100699_bb0105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12875-022-01821-9","article-title":"Evaluation of a pharmacist-led intervention to improve medication adherence in patients initiating dabigatran treatment: a comparison with standard pharmacy practice in Poland","volume":"23","author":"Merks","year":"2022","journal-title":"BMC Prim Care"},{"key":"10.1016\/j.rcsop.2025.100699_bb0110","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.942923","article-title":"Enhancing patient adherence to newly-prescribed medicine for chronic diseases: a comprehensive review and cost-effective approach to implementing the new medicine Service in Community Pharmacies in Poland","volume":"30","author":"Merks","year":"2024","journal-title":"Med Sci Monit"},{"issue":"16","key":"10.1016\/j.rcsop.2025.100699_bb0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s40545-023-00626-0","article-title":"Global landscape of community pharmacy services remuneration: a narrative synthesis of the literature","volume":"9","author":"Hussain","year":"2023","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.rcsop.2025.100699_bb0120","article-title":"New medicine service by community pharmacists: an opportunity to enhance universal health coverage at a primary health level in South Africa","volume":"60","author":"Naidoo","year":"2023","journal-title":"Inquiry"},{"issue":"10","key":"10.1016\/j.rcsop.2025.100699_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmjqs-2015-004400","article-title":"Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the new medicine service","volume":"25","author":"Elliott","year":"2015","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.rcsop.2025.100699_bb0130","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1016\/j.sapharm.2022.06.005","article-title":"Drug-related problems and satisfaction among patients receiving pharmacist-led consultations at the initiation of cardiovascular drugs","volume":"18","author":"Bremer","year":"2022","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2025.100699_bb0135","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s40273-017-0554-9","article-title":"Cost effectiveness of support for people starting a new medication for a long-term condition through community pharmacies: an economic evaluation of the new medicine service (NMS) compared with Normal practice","volume":"35","author":"Elliott","year":"2017","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.rcsop.2025.100699_bb0140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/bmjqs-2018-009177","article-title":"\u2018New medicine service\u2019: supporting adherence in people starting a new medication for a long-term condition: 26-week follow-up of a pragmatic randomised controlled trial","volume":"29","author":"Elliott","year":"2020","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.rcsop.2025.100699_bb0145","article-title":"Report: evaluation of Medisinstart. MENON","volume":"No. 44\/2022","author":"Stokke","year":"2022","journal-title":"Publication"},{"key":"10.1016\/j.rcsop.2025.100699_bb0150","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.18549\/PharmPract.2020.2.1927","article-title":"Community pharmacy and primary health care in Sweden - at a crossroads","volume":"18","author":"Westerlund","year":"2020","journal-title":"Pharm Pract (Granada)"},{"key":"10.1016\/j.rcsop.2025.100699_bb0155","author":"Swedish Pharmacy Association"},{"key":"10.1016\/j.rcsop.2025.100699_bb0160","author":"The Swedish National Financial Management Authority (Ekonomystyrningsverket)"},{"key":"10.1016\/j.rcsop.2025.100699_bb0165","first-page":"1","article-title":"Implementation of trial activities with Apoteken\u2019s drug consultations. In","volume":"1","year":"2023","journal-title":"Swedish"},{"issue":"8","key":"10.1016\/j.rcsop.2025.100699_bb0170","article-title":"Understanding patients\u2019 adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework","volume":"2","author":"Horne","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.rcsop.2025.100699_bb0175","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","article-title":"The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research","volume":"24","author":"Ludvigsson","year":"2009","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.rcsop.2025.100699_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.37737\/ace.22005","article-title":"Introduction to matching in case-control and cohort studies","volume":"4","author":"Iwagami","year":"2022","journal-title":"Ann Clin Epidemiol"},{"key":"10.1016\/j.rcsop.2025.100699_bb0185","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish prescribed drug register\u2014opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.rcsop.2025.100699_bb0190","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.rcsop.2025.100699_bb0195","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register","volume":"32","author":"Brooke","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.rcsop.2025.100699_bb0200","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","article-title":"The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research","volume":"34","author":"Ludvigsson","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.rcsop.2025.100699_bb0205","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.clinthera.2006.09.021","article-title":"Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization","volume":"28","author":"Caetano","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.rcsop.2025.100699_bb0210","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/jama.2018.19271","article-title":"Interventions to improve medication adherence: a review","volume":"320","author":"Kini","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.rcsop.2025.100699_bb0215","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ypmed.2017.03.008","article-title":"Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis","volume":"99","author":"Conn","year":"2017","journal-title":"Prev Med"},{"issue":"3","key":"10.1016\/j.rcsop.2025.100699_bb0220","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10654-025-01221-0","article-title":"Diagnostic accuracy in the Swedish national patient register: a review including diagnoses in the outpatient register","volume":"40","author":"Everhov","year":"2025","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.rcsop.2025.100699_bb0225","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1377\/hlthaff.2013.1398","article-title":"The Pennsylvania project: pharmacist intervention improved medication adherence and reduced health care costs","volume":"33","author":"Pringle","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100699_bb0230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.sapharm.2013.03.001","article-title":"Pharmacist-patient communication in Swedish community pharmacies","volume":"10","author":"Olsson","year":"2014","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2025.100699_bb0235","series-title":"Pharmacy Medicine Consultations \u2013 Pharmacists\u2019 Experiences. Report to the Swedish Pharmacy Association, Uppsala University, Department of pharmacy f\u00f6r Farmaci","author":"K\u00e4lvemark Sporrong","year":"2024"},{"key":"10.1016\/j.rcsop.2025.100699_bb0240","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.pec.2015.04.002","article-title":"How can we promote patient recall of information from medical consultations?","volume":"98","author":"Finset","year":"2015","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.rcsop.2025.100699_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242424","article-title":"Statin adherence is lower in primary than secondary prevention: a national follow-up study of new users","volume":"15","author":"Sigglekow","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.rcsop.2025.100699_bb0250","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ahj.2013.02.011","article-title":"Gender and racial disparities in adherence to statin therapy: a meta-analysis","volume":"165","author":"Lewey","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.rcsop.2025.100699_bb0255","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1345\/aph.1P150","article-title":"Predictors of nonadherence to statins: a systematic review and meta-analysis","volume":"44","author":"Mann","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rcsop.2025.100699_bb0260","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.pec.2016.01.020","article-title":"Health literacy and adherence to medical treatment in chronic and acute illness: a meta-analysis","volume":"99","author":"Miller","year":"2016","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.rcsop.2025.100699_bb0265","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bcpt.12613","article-title":"The first decade with the Swedish prescribed drug register - a systematic review of the output in the scientific literature","volume":"119","author":"Wallerstedt","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.rcsop.2025.100699_bb0270","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024)","year":"2024"},{"key":"10.1016\/j.rcsop.2025.100699_bb0275","article-title":"Understanding the Hawthorne effect","volume":"351","author":"Sedgwick","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.rcsop.2025.100699_bb0280","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bcp.12339","article-title":"Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review","volume":"78","author":"De Vera","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2025.100699_bb0285","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.2174\/138161211798220891","article-title":"Statin discontinuation in high-risk patients: a systematic review of the evidence","volume":"17","author":"Gomez Sandoval","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.rcsop.2025.100699_bb0290","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jacl.2010.08.026","article-title":"The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review","volume":"4","author":"Simpson","year":"2010","journal-title":"J Clin Lipidol"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276625001404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276625001404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:58:24Z","timestamp":1775181504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276625001404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":58,"alternative-id":["S2667276625001404"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2025.100699","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved persistence to statin therapy through a patient counseling intervention in community pharmacies \u2013 A nationwide cohort study","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2025.100699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100699"}}